Vimarsana
Biggest News Aggregation in the World

Page 18 - Regarding Use News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Regarding Use. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Regarding Use Today - Breaking & Trending Today

Airgain® Reports First Quarter 2023 Financial Results - Vimarsana News

Airgain® Reports First Quarter 2023 Financial Results

Airgain, Inc. , a leading provider of wireless connectivity solutions that creates and delivers embedded components, external antennas, and integrated systems across the globe, today reported... | May 11, 2023

GoPro Announces First Quarter 2023 Results - Vimarsana News

GoPro Announces First Quarter 2023 Results

Revenue of $175 million was 6% Above Guidance on Stronger DemandGoPro Subscribers Grew 36% Year-over-Year to 2.36 millionSubscription and Service ...

Performant Financial Corporation Announces Financial Results for First Quarter 2023 - Vimarsana News

Performant Financial Corporation Announces Financial Results for First Quarter 2023

Performant Financial Corporation , a leading provider of technology-enabled audit, recovery, and related analytics services in the United States with a focus in the healthcare payment integrity... | May 9, 2023

InnovAge Announces Financial Results For The Fiscal Third Quarter Ended March 31, 2023 - Vimarsana News

InnovAge Announces Financial Results For The Fiscal Third Quarter Ended March 31, 2023

DENVER, Colo., May 09, 2023 -- InnovAge Holding Corp. , an industry leader in providing comprehensive healthcare programs to frail dual-eligible seniors through the Program of All-inclusive Care... | May 9, 2023

Glaukos Announces First Quarter 2023 Financial Results - Vimarsana News

Glaukos Announces First Quarter 2023 Financial Results

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced financial results for the first quarter ended March 31, 2023. Key highl...